2-[4-[[6-[2-(4-fluorophenyl)ethylcarbamoyl]-4-methyl-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
C34H32FN3O3 — CID 57380649
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[6-[2-(4-fluorophenyl)ethylcarbamoyl]-4-methyl-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
2-[4-[[6-[2-(4-fluorophenyl)ethylcarbamoyl]-4-methyl-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid (PubChem CID 57380649) has the molecular formula C34H32FN3O3 and a molecular weight of 549.65 g/mol. Its IUPAC name is 2-[4-[[6-[2-(4-fluorophenyl)ethylcarbamoyl]-4-methyl-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid.
Molecular Properties
| Compound Name | 2-[4-[[6-[2-(4-fluorophenyl)ethylcarbamoyl]-4-methyl-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid |
|---|---|
| PubChem CID | 57380649 |
| Molecular Formula | C34H32FN3O3 |
| Molecular Weight | 549.65 g/mol |
| Exact Mass | 549.24 |
| IUPAC Name | 2-[4-[[6-[2-(4-fluorophenyl)ethylcarbamoyl]-4-methyl-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid |
| SMILES | CCCc1nc2c(C)cc(C(=O)NCCc3ccc(F)cc3)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1 |
| InChI | InChI=1S/C34H32FN3O3/c1-3-6-31-37-32-22(2)19-26(33(39)36-18-17-23-11-15-27(35)16-12-23)20-30(32)38(31)21-24-9-13-25(14-10-24)28-7-4-5-8-29(28)34(40)41/h4-5,7-16,19-20H,3,6,17-18,21H2,1-2H3,(H,36,39)(H,40,41) |
| InChIKey | SGICQOPXUHBZIZ-UHFFFAOYSA-N |
| XLogP | 6.82 |
| TPSA | 84.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 549.65 |
| LogP ≤ 5 | 6.82 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 57380649 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.